Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Discover the key moments to adjust a zero based budget to ensure it aligns with your financial goals and maximizes savings.
18,874 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Institutional moves are reshaping exposure to China as the market resets. This article explains what happened with mi...
As AI reshapes design tools, a Claude-powered tie-up could shift Figma's growth trajectory. This article breaks down ...
A stock that surged 49% in 2025 can still be tempting in 2026. This guide breaks down how to assess a semiconductor p...
NVIDIA is backing two optics-focused AI companies with billions of dollars, a move that helped them earn spots in the...
Markets pull back in early 2026 amid geopolitical tensions. This article highlights three dividend-focused ETFs that ...
Valuations look stretched, but a peak can be a buying opportunity or a pause before the next leg up. This guide break...
XRP has surged past BNB to claim the fourth-largest spot by market capitalization as Ripple unveils a Brazil expansio...
Freshworks unveils a $400 million share repurchase as it shifts to AI-based pricing, prompting investor debate over w...
AI is nearing a dramatic turning point. Wedbush predicts a 2026 inflection, and this article explains what that means...
Geopolitical risk in the Middle East adds new headwinds for Nvidia, threatening its Taiwan-based chip supply chain an...
When a space company announces a bold acquisition, investors sit up. This article breaks down what york space buys al...